Nonetheless, previous studies have demonstrated that NOX2 and NOX4 are frequently upregulated in ovarian cancer and play pivotal roles in tumor progression, chemoresistance, and redox homeostasis [37,38,39,40]. The gene discussed is CYBB; the disease is ovarian cancer.